•
Jun 30, 2019

Edwards Lifesciences Q2 2019 Earnings Report

Total Revenue
$1.09B
Previous year: $944M
+15.2%
EPS
$0.46
Previous year: $0.41
+12.2%
Gross Profit Margin
72%
SG&A Expenses
$308M
R&D Expenses
$192M
Gross Profit
$783M
Previous year: $698M
+12.2%
Cash and Equivalents
$727M
Previous year: $1.23B
-40.7%
Free Cash Flow
$277M
Previous year: $87.4M
+216.5%
Total Assets
$5.57B
Previous year: $5.69B
-2.0%

Edwards Lifesciences

Edwards Lifesciences

Edwards Lifesciences Revenue by Segment

Edwards Lifesciences Revenue by Geographic Location

Revenue & Expenses

Visualization of income flow from segment revenue to net income